171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA
Reports Second Quarter 2026 Financial Results and Provides Business Update
Lease Termination Agreement with Terreno Park Union City LLC
Appoints Eric Hyllengren as Chief Financial Officer
Tenaya Therapeutics Amends 2021 Equity Incentive Plan; Share Increase Approved
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Collaboration Agreement with Alnylam Pharmaceuticals for Cardiovascular Research
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence